One-of-a-Kind genetic drug trial launched for single Patient's rare eye disease
NCT ID NCT07177196
Summary
This study is testing a personalized genetic drug designed for a single patient with a rare form of inherited retinal dystrophy. The goal is to see if the custom treatment is safe and if it can help slow or stop the progression of vision loss. Researchers will carefully monitor the patient's eyes and vision over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL DYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California San Diego
San Diego, California, 92093, United States
Conditions
Explore the condition pages connected to this study.